CHAMPIONS ONCOLOGY, INC. Increase (Decrease) in Other Current Liabilities
CHAMPIONS ONCOLOGY, INC. (CSBR) reported Increase (Decrease) in Other Current Liabilities of $0 for the 9-month period ending 2023-01-31, per its 10-Q filed 2023-03-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentLiabilities · last filed 2023-03-16
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in other current liabilities for the quarter ending 2023-01-31 was $0.00.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in other current liabilities for the quarter ending 2022-10-31 was $0.00.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in other current liabilities for the quarter ending 2022-07-31 was $0.00, a 100.00% decline year-over-year.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in other current liabilities for the quarter ending 2022-01-31 was $0.00.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in other current liabilities for fiscal 2012 was $0.00.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in other current liabilities for fiscal 2011 was -$77.00K.
| Period end | Increase (Decrease) in Other Current Liabilities 3 month | Increase (Decrease) in Other Current Liabilities 6 month | Increase (Decrease) in Other Current Liabilities 9 month | Increase (Decrease) in Other Current Liabilities 12 month |
|---|---|---|---|---|
| 2023-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-03-16 | $0.00 derived: sum of 2 quarters · filed 2023-03-16 | $0.00 10-Q · filed 2023-03-16 | |
| 2022-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-12-13 | $0.00 10-Q · filed 2022-12-13 | ||
| 2022-07-31 | $0.00 10-Q · filed 2022-09-12 | |||
| 2022-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-03-16 | $0.00 derived: sum of 2 quarters · filed 2023-03-16 | $15.00K 10-Q · filed 2023-03-16 | |
| 2021-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-12-13 | $15.00K 10-Q · filed 2022-12-13 | ||
| 2021-07-31 | $15.00K 10-Q · filed 2022-09-12 | |||
| 2021-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-03-15 | $0.00 derived: sum of 2 quarters · filed 2022-03-15 | $0.00 10-Q · filed 2022-03-15 | |
| 2020-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-12-13 | $0.00 10-Q · filed 2021-12-13 | ||
| 2020-07-31 | $0.00 10-Q · filed 2021-09-13 | |||
| 2012-04-30 | $0.00 10-K · filed 2012-07-18 | |||
| 2011-04-30 | -$77.00K 10-K · filed 2012-07-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |